BARDA Industry Day 2011

Day 1 - Tuesday, June 7, 2011

icon G Kovacs: CBRN Advanced Research and Development & Project Bioshield
icon J Larsen: Broad Spectrum Antimicrobial Program
icon J Schafer: Stockpiling Influenza, Antiviral Drugs & Other Countermeasures
icon M Perdue: Pandemic Influenza & Countermeasures Portfolio
icon M Lawlor: New Broad Agency Announcement for Influenza
icon M Merchlinksky: Smallpox Vaccines Program
icon M Willis: Botulism Medical Countermeasures
icon R Bright: Advanced Development New Antivirals
icon R Huebner: Advanced Development Of New Influenza Vaccines
icon R Manning: CBRN Medical Countermeasures
icon R Shively: Influenza Rapid Diagnositcs
icon R Wallace: Diagnostics And Biodosimetry Programs
icon Tom Dreier: Anthrax Vaccine Countermeasures
icon Terri Richards: Anthrax Therapeutics MCMs
icon Vittoria Cioce: Influenza Vaccine and Adjuvant Stockpiles

Day 2 - Wednesday, June 8, 2011

icon Andre Early: How to Respond to an RFP
icon Brian Goodger: Mock T.E.P.
icon Carl Ruggiero: Earned Value Management
icon Famane Brown: Small Business Administration
icon Glynis Fisher and Carolyn Keeseman: Broad Agency Announcements
icon Glynis Fisher and John Ablard: Other Transaction Authority
icon Jolinda Summers: Decision Gate - Business Toolkit

Day 3 - Thursday, June 9, 2011

icon A Liss: Update on FDA's Regulatory Science Initiative
icon B Dattilo: Communicating with BARDA
icon B Datillo: Programs to Foster Technological Innovation
icon D Yeskey: Emergency Use of MCM's
icon D Yeskey: RQA Introduction
icon J Schweinle: Division of Clinical Studies
icon J Seals: Strategic Science and Technology
icon L Borek: Diagnostic MCM Regulatory Lessons Learned
icon Rosemary Roberts: What FDA Expects
icon S Sensabaugh: What FDA Expects
icon T Warf: Division Of Manufacturing Facilities And Engineering Programs